Emelie Gezelius

Randomized phase III trial of low-molecular-weight heparin enoxaparin in addition to standard treatment in small-cell lung cancer: the RASTEN trial

L. Ek, Emelie Gezelius, Bengt Bergman et al. · Annals of Oncology · 2017 · 69 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +13

Coagulation biomarkers and prediction of venous thromboembolism and survival in small cell lung cancer: A sub-study of RASTEN - A randomized trial with low molecular weight heparin

Emelie Gezelius, Anne Flou Kristensen, Pär‐Ola Bendahl et al. · PLoS ONE · 2018 · 54 citations · Full text

Medicine, Hematology, Oncology +17

Protumoral lipid droplet–loaded macrophages are enriched in human glioblastoma and can be therapeutically targeted

Valeria Governa, Kelin Gonçalves de Oliveira, Anna Bång-Rudenstam et al. · Science Translational Medicine · 2024 · 40 citations

Medicine, Immunology, Oncology +17

Longitudinal Assessment of Circulating Tumor Cells and Outcome in Small Cell Lung Cancer: A Sub-Study of RASTEN—A Randomized Trial with Low Molecular Weight Heparin

Pär‐Ola Bendahl, Mattias Belting, Emelie Gezelius · Cancers · 2023 · 11 citations · Full text

Medicine, Hematology, Oncology +17